March 20, 2018 | Commercialization, Manufacturing

[The Cell Culture Dish Podcast] Opportunities and Challenges in Cell Therapy Manufacturing

Dr. Robert Preti joins The Cell Culture Dish in advance of his upcoming keynote at CBI's Optimization of Cell and Gene Therapy Production Conference. The Cell Culture Dish states;

In this podcast and accompanying we interviewed Dr. Robert Preti about the past, present and future of global cell therapy manufacturing. We also discussed major industry milestones, manufacturing challenges and opportunities for the further improvements.

In the closing of the interview, Dr. Preti states "this is the most exciting time to be in this industry." Click below to listen to the podcast or click here to read more.

Read Show Notes

Join us at CBI's Optimization of Cell and Gene Therapy Production conference March 26-27 to hear from Dr. Robert Preti. Other PCT team experts, Brian Hampson and Dr. Courtney LeBlon, speak on the Development by Design methodology and best practices for closed processing and automation development. Please contact us if you have any questions.

*This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, formerly PCT or PCT Cell Therapy Services), apceth Biopharma GmbH are all now operating under the name Minaris Regenerative Medicine. Hitachi Chemical Co., Ltd. has been renamed Showa Denko Materials Co., Ltd.

Stay up to date on the latest cell therapy industry insights

Related Articles

November 2, 2017

Robert Preti, PhD, Opens the 2017 Cell & Gene Meeting on the Mesa

At this year's Cell & Gene Meeting on the Mesa, Robert Preti, PhD, Chairman of the Alliance for Regenerative Medicine and President and CEO of Hitachi Chemical Advanced Therapeutics ...

Read More
September 15, 2015

Spreading the Word on the Future of Commercial Cell Therapy Manufacturing– PCT Heads to IBC

At the end of this month, two of my colleagues and I have the opportunity to speak at the IBC Life Sciences Cell Therapy Bioprocessing and Commercialization Conference in Alexandria, ...

Read More
December 20, 2017

The Calculus for Success and the Nature of Innovation in the Cell Therapy Industry

As I contemplate the future landscape of this cell and gene-based medicine industry and how best it can be navigated, I am always less certain of precisely what the future holds in terms of ...

Read More